Be our partner
We continually innovate and improve our technology platform to more accurately predict factors relevant to cancer drug development.
We are happy to explore research or development collaborations.
Let´s talk
Flexible agreements and partnerships
We offer flexible agreements that can range from any combination of de novo discovery to lead optimization
Range of offers
We identify new potential inhibitors, determine the possible mechanism of action, look for the most optimal combinations between drugs, and help develop other solutions such as ADCs, PROTACs and nanoparticles.
Academic Collaborations
We collaborate with academic institutions on research projects that could benefit from our technology and experience.
CRO Parterships
We establish strategic partnerships with CROs and service providers who can provide reliable and innovative offerings that complement our tech platform capabilities.
Some of our academic partners
